SMITHS FALLS, ON and
SAINT LUCIEN, QC, Dec. 21, 2017 /CNW/ - Canopy Growth
Corporation (TSX: WEED) ("Canopy Growth" or the "Company") is
pleased to announce that its wholly-owned subsidiary Vert
Cannabis in Saint Lucien,
Québec, has obtained a production license under the Access to
Cannabis for Medical Purposes Regulations ("ACMPR"). Vert
Cannabis is a 7000 square foot craft cannabis production
facility located in the small town of Saint Lucien, Québec.
"We're pleased to have obtained the licence and look forward to
starting cannabis production in Québec," said Adam Greenblatt, Québec Brand Manager at Canopy
Growth and cannabis industry pioneer. "The licensing of
Vert Cannabis in Saint
Lucien, combined with the recently announced Vert
Mirabel joint venture with
Les Serres Bertrand,
positions Canopy Growth as Québec's leader in both craft-scale
indoor production and large-scale greenhouse production."
Vert Cannabis was acquired by Canopy Growth in November
of 2016 as a part of the Company's overall growth strategy and
commitment to developing the cannabis market in Québec,
Canada's second-largest province.
Vert Cannabis represents Canopy's seventh Canadian
production licence under the ACMPR to-date. Vert will begin
production in Q1 of 2018 following the live transfer of starter
plants from the Tweed facility in
Smiths Falls, Ontario.
"Medical cannabis and the full legalization of adult use
represents a tremendous opportunity for Québec to improve public
health and safety, and to provide consumers with access to cannabis
products of known potency and provenance," said Greenblatt.
"It is an exciting privilege to operate at the intersection
of revolutionary policy reform and a nascent commercial sector with
vast potential, and as such, we are dedicated to establishing a
vibrant, competitive, and socially responsible cannabis industry
here in Québec."
Poussons Vert l'avenir.
About Canopy Growth Corporation
Canopy Growth is a
world-leading diversified cannabis and hemp company, offering
distinct brands and curated cannabis varieties in dried, oil and
Softgel capsule forms. From product and process innovation to
market execution, Canopy Growth is driven by a passion for
leadership and a commitment to building a world-class cannabis
company one product, site and country at a time.
Canopy Growth has established partnerships with leading sector
names including cannabis icon Snoop Dogg, breeding legends DNA
Genetics and Green House seeds, and Fortune 500 alcohol leader
Constellation Brands, to name but a few. Canopy Growth operates
seven cannabis production sites with over 665,000 square feet of
production capacity, including over 500,000 square feet of
GMP-certified production space. The Company has operations in seven
countries across four continents. The Company is proudly dedicated
to educating healthcare practitioners, conducting robust clinical
research, and furthering the public's understanding of cannabis,
and through its partly owned subsidiary, Canopy Health Innovations,
has devoted millions of dollars toward cutting edge,
commercializable research and IP development. Through partly owned
subsidiary Canopy Rivers Corporation, the Company is providing
resources and investment to new market entrants and building a
portfolio of stable investments in the sector. From our historic
public listing to our continued international expansion, pride in
advancing shareholder value through leadership is engrained in all
we do at Canopy Growth. For more information visit
www.canopygrowth.com
Notice Regarding Forward Looking Statements
This news
release contains forward-looking statements. Often, but not always,
forward-looking statements can be identified by the use of words
such as "plans", "expects" or "does not expect", "is expected",
"estimates", "intends", "anticipates" or "does not anticipate", or
"believes", or variations of such words and phrases or state that
certain actions, events or results "may", "could", "would", "might"
or "will" be taken, occur or be achieved. Forward-looking
statements involve known and unknown risks, uncertainties and other
factors which may cause the actual results, performance or
achievements of Canopy Growth Corporation, its subsidiaries, or its
affiliates to be materially different from any future results,
performance or achievements expressed or implied by the
forward-looking statements. Examples of such statements include
future operational and production capacity, the impact of enhanced
infrastructure and production capabilities, and forecasted
available product selection. The forward-looking statements
included in this news release are made as of the date of this news
release and Canopy Growth Corporation does not undertake an
obligation to publicly update such forward-looking statements to
reflect new information, subsequent events or otherwise unless
required by applicable securities legislation.
Neither the TSX Exchange nor its Regulation Services Provider
(as that term is defined in policies of the TSX Exchange) accepts
responsibility for the adequacy or accuracy of this release.
SOURCE Canopy Growth Corporation